decor

Testosterone Replacement Therapy Settlement

Seeger Weiss helped secure compensation for people who were injured by testosterone replacement medications, including two cases which resulted in settlements totaling $290 million for the plaintiffs. Additionally, thousands of federal testosterone replacement drug injury cases have been settled through Multidistrict Litigation.

Sign up for our newsletter to get updates on drugs & medical devices

If you would like to sign up for our newsletter click the button below.

Sign Up For Newsletter

$290 Million Drug Injury Settlement

In two separate jury trials, plaintiffs won a total of $290 million in damages in testosterone drug injury lawsuits against AndroGel manufacturer, AbbVie. Plaintiffs claimed use of the testosterone replacement therapy medication resulted in serious cardiovascular injuries. Manufacturers were also accused of inappropriately marketing testosterone medications for symptoms of “low-T” related to normal aging.

In May of 2018, the $150 million verdict was reduced in a second trial after the initial verdict was overturned but the company moved forward with a tentative agreement to settle 4,200 AndroGel drug injury lawsuits for an undisclosed amount. Separately, in 2017 Eli Lilly had agreed to settle 400 federal Axiron lawsuits and Endo International, along with GlaxoSmithKline agreed to settle 1,300 testosterone lawsuits for an estimated $200 million.

Notwithstanding claims relating to this product, the drug/medical device remains approved by the U.S. FDA.

Sign up for our newsletter here.

Enter your email to get updates from Drugdangers

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. After submitting, you will be contacted by one of DrugDanger’s trusted legal partners. This is legal advertising.

Sign up to keep up to date with accurate law news.

2024 Drug Dangers.com

All rights reserved

NOTICE: This website, the related links, and the social media accounts of Seeger Weiss contain Attorney Advertising. No aspect of this or any advertisement has been approved by the Supreme Court of New Jersey. Seeger Weiss’ websites and social media accounts are designed for general information only. The information contained on Seeger Weiss’ websites and social media accounts should not be construed as legal advice, should not be relied upon as a substitute for the retention of an attorney or for independent legal research, and does not create an attorney-client relationship. The materials presented by this website are not medical advice, and are not a substitute for the opinion of a qualified healthcare professional. Seeger Weiss LLP routinely represents clients for alleged personal injuries, including injuries sustained due to use of prescription drugs and medical devices. Do not stop taking a prescribed medication or stop using a prescribed medical device without first consulting with your doctor. Discontinuing a prescribed medication or use of a prescribed medical device without your doctor’s advice can result in injury or death. Notwithstanding claims relating to certain drugs and medical devices, the drug or medical device may remain approved by the U.S. FDA. An endorsement of the firm or report of prior results does not guarantee or predict a similar outcome with respect to any future matter. Firm only practices law where permitted through proper admission, licensure or court approval. This ad is limited to specific litigation, not general legal services, and is not intended to solicit legal representation that would constitute the unauthorized practice of law in any jurisdiction. Provision of information as to your experience does not create an attorney-client relationship, no attorney-client relationship is formed until execution of a retainer agreement.

↑